These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5047465)

  • 21. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V
    Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
    [No Abstract]   [Full Text] [Related]  

  • 22. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin.
    Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S
    J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytostatic effect of vinylogous nitrogen mustard carbonamidium salts against transplanted tumors in an automatic preliminary test and a sequential test program].
    Gutsche W; Jungstand W; Wohlrabe K; Fischer GW; Lohs K
    Arch Geschwulstforsch; 1972; 39(2):121-7. PubMed ID: 5065117
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antitumor action of phenylalanine derivatives of mechlorethamine (author's transl)].
    Zhou JX; Liang HZ; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):121-8. PubMed ID: 6461211
    [No Abstract]   [Full Text] [Related]  

  • 25. [Correlations between chemical structure and biological activity of azomethines with nitrogen-mustard-groups on Ehrlich ascites tumor in albino mice. 3. Activation of N-mustard-azomethines by cells of Ehrlich ascites carcinoma].
    Schulze W; Horn G
    Arzneimittelforschung; 1970 Mar; 20(3):329-35. PubMed ID: 5467506
    [No Abstract]   [Full Text] [Related]  

  • 26. [Distribution of asaphan-C14 in the organs of both sexes].
    Lobova TG; Sof'ina ZP
    Vopr Onkol; 1968; 14(10):79-82. PubMed ID: 5724802
    [No Abstract]   [Full Text] [Related]  

  • 27. [In vitro and in vivo experiments on multiple-step cancer therapy; attack induction by alkylating cytostatics].
    von Ardenne M; Chaplain RA; Reitnauer PG
    Dtsch Gesundheitsw; 1969 Sep; 24(38):1781-7. PubMed ID: 5376244
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy of neoplasms].
    Osswald H
    Hippokrates; 1967 Jul; 38(13):497-506. PubMed ID: 5611578
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the antitumor activity of sigma, N1N-bis(beta-chlorethyl)-L-lysine (lysepsis)].
    Snasskaia IG; Larionov LF
    Vopr Onkol; 1966; 12(9):66-70. PubMed ID: 6004071
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of melphalan resistance developed in vitro in human melanoma cells.
    Parsons PG; Carter FB; Morrison L; Regius Mary Sister
    Cancer Res; 1981 Apr; 41(4):1525-34. PubMed ID: 6163526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship of labeled molecules in the pharmacokinetic study of alkylating agents (chlorambucil, melphalan, mitoclomine) and glycosyl nitrosoureas (RFCNU and RPCNU)].
    Meyniel G; Godenech D
    Nouv Rev Fr Hematol (1978); 1979; Suppl():XXXIII-XXXV. PubMed ID: 545309
    [No Abstract]   [Full Text] [Related]  

  • 32. The 5'-GNC preference for mustard cross-linking is preserved in a restriction fragment.
    Millard JT; Luedtke NW; Spencer RJ
    Anticancer Drug Des; 1996 Sep; 11(6):485-92. PubMed ID: 8836112
    [No Abstract]   [Full Text] [Related]  

  • 33. Attempt to increase the effect of regional chemotherapy in experimental tumours by procaine.
    Godál A; Medzihradský J; Knotek J; Ujházy V
    Neoplasma; 1969; 16(4):389-92. PubMed ID: 5344224
    [No Abstract]   [Full Text] [Related]  

  • 34. A study on immunological therapy for cancer by using nitrogen mustard-treated cancer tissue.
    Asakuma R; Yokoyama I
    Nihon Geka Hokan; 1965 Nov; 34(6):1413-29. PubMed ID: 5893249
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential anticancer agents. I. A nitrogen mustard based on orotic acid.
    Danielsson B; Bogentoft C; Ljungnér F
    Acta Pharm Suec; 1968 Sep; 5(4):279-82. PubMed ID: 5724370
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of resistance of Yoshida sarcoma to nitrogen mustard. II. Further evidence for suppressed transport of nitrogen mustard.
    Inaba M; Moriwaki A; Sakurai Y
    Int J Cancer; 1972 Sep; 10(2):411-7. PubMed ID: 4676767
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of steroids as carriers of cytotoxic agents in breast cancer: estrogens linked with nitrogen mustard groups [proceedings].
    Lippman M
    Cancer Treat Rep; 1978 Aug; 62(8):1259-60. PubMed ID: 688264
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tumour chemotherapy: syntheses of N-phosphorylated nitrogen mustards and related compounds].
    Kao WI; Ho HY; Song CW; Li MM; Cheng BL
    Yao Xue Xue Bao; 1965 Oct; 12(10):672-7. PubMed ID: 5898992
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on treatment with antitumor agents--short-term observations on the effects in vitro].
    Katsuta K; Hisatsune K; Kajiyama M; Miyahara H; Atsumi T
    Iryo; 1967 Oct; 21(10):1183-92. PubMed ID: 5590371
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood protein picture in inoperable and with nitrogen mustard treated bronchial carcinoma].
    SCHULZ FH; KETTWIG W
    Z Gesamte Inn Med; 1954 Jul; 9(13):648-51. PubMed ID: 13206165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.